OptimizeRx Corp — Director's Dealing 2023

Mar 3, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2023-03-01

Reporting Person: Silvestro Stephen L (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-03-01	Common Stock	M	1927	—	Acquired	5127	Direct
2023-03-01	Common Stock	F	668	$18.11	Disposed	4459	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-03-01	Restricted Stock Units	$	M	1927	Disposed		Common Stock (1927.0)	Direct

Footnotes

F1: Restricted stock units convert into common stock on a one-for-one basis.

F2: These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.

F3: The restricted stock units vest in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date.